Clinical Studies Registered Nurse II, Clinical Research Unit​/Sleep Medicine

Clinical Studies Registered Nurse II, Clinical Research Unit/Sleep Medicine

Join to apply for the Clinical Studies Registered Nurse II, Clinical Research Unit/Sleep Medicine role at Atrium Health Wake Forest Baptist
.

1 day ago – Be among the first 25 applicants.

36621 Wake Forest University Health Sciences – Nursing Psychiatric

Full time

Yes

40

Various hours. Some weekends/nights required.

$37.50 – $56.25

Provides specialized nursing care/treatment to a specific group of patients who are participating in clinical research studies within the Wake Forest Baptist Comprehensive Cancer Center (WFBCCC). Functions as part of a research team that may consist of Investigators, Clinical Studies Coordinators, Data Managers, Regulatory Coordinators, and other Nursing Staff. Under the direction of the Investigator, the Clinical Research Nurse II is responsible for subject recruitment, eligibility, enrollment, informed consent, retention, education, and protocol adherence.

Clinical responsibilities include administering investigational therapies, monitoring toxicities, assessing clinical response and providing exemplary patient care while ensuring the protocol is conducted in a high‑quality manner. Conducts clinical research in compliance with Clinical Protocol and Data Management (CPDM), state, and federal guidelines. Communicates research‑related information to patients, families, nursing, and medical staff as necessary. Primary focus is Sleep Medicine; some pediatric experience preferred.

• Associate’s degree in Nursing from an accredited School of Nursing with one year of nursing experience, preferably in a related field, research, acute care, or a specialty area (specifically, Oncology).
• Bachelor’s degree in Nursing with two or more years of nursing experience preferred.
• Documented education and/or training in the oncology field preferred.
• Pediatric experience preferred.

• Licensure as a Registered Nurse (RN) in applicable state required.
• Must complete the CITI certification for Human Subject Research if not already completed and any additional required Wake One training for research coordinators.

• Works under the direction/supervision of the Study Investigators, Disease Team Chair, and the Clinical Research Nurse Manager. Also receives supervision and mentoring from the Nurse Team Leader.
• Works in conjunction with a Research Nurse mentor and the oversight of a Nurse Team Leader to assume gradually more responsibility and workload.
• Knowledge and understanding of policies, procedures, and regulations governing human subject’s research incorporates them in the conduct of research and care of participants.
• Actively screens patients for protocol enrollment, utilizing knowledge of oncology nursing to review pathology, laboratory results, scans and physician notes to verify patient eligibility.
• Independently uses and documents the nursing process to plan, deliver and evaluate goal‑focused, individualized, safe, age‑specific care as it relates to uncomplicated research participants and with assistance for complicated research participants.
• Coordinates patient schedules and provides information for a successful visit to meet the required protocol procedures, data collection time points and nursing care.
• With supervision, manages dose modifications and/or other modifications of the treatment regimen made in response to toxicity, pharmacokinetics, and tissue studies.
• Serves as a nursing expert of specialized patient care, including direct patient care, assessment, documentation, treatment intervention and patient/family education and support in accordance with education/experience, established policies and procedures, and state licensure requirements.
• Works with WFBCCC investigators and staff to maximize identification of eligible study patients for recruitment to research protocols either by referrals or from the current pool of clinical patients. Recruits, consents, and enrolls patients onto trials once eligible patients are identified.
• T…